Literature DB >> 9642070

Three-dimensional structures of single-chain Fv-neuraminidase complexes.

R L Malby1, A J McCoy, A A Kortt, P J Hudson, P M Colman.   

Abstract

The structure of the complex between a recombinant single-chain Fv construct of antibody NC10 with a five-residue peptide linker between VH and VL (termed scFv(5)), and its antigen, tetrameric neuraminidase from influenza virus (NA), has been determined and refined at 2.5 A resolution. The antibody-antigen binding interface is very similar to that of a similar NC10 scFv-NA complex in which the scFv has a 15-residue peptide linker (scFv(15)), and the NC10 Fab-NA complex. However, scFv(5) and scFv(15) have different stoichiometries in solution. While scFv(15) is predominantly monomeric in solution, scFv(5) forms dimers exclusively, because the five-residue linker is not long enough to permit VH and VL domains from the same polypeptide associating and forming an antigen-binding site. Upon forming a complex with NA, scFv(15) forms a approximately 300 kDa complex corresponding to one NA tetramer binding four scFv(15) monomers, while scFv(5) forms a approximately 590 kDa complex, corresponding to two NA tetramers crosslinked by four bivalent scFv(5) dimers. However, the dimeric scFv(5) in the scFv(5)-NA crystals does not crosslink NA tetramers, and modelling studies indicate that it is not possible to pack four dimeric and simultaneously bivalent scFvs between the NA tetramers with only a five-residue linker between VH and VL. The inability arises from the exacting requirement to orient the two antigen-binding surfaces to bind the tetrameric NA antigen while avoiding steric clashes with NC10 scFv(5) dimers bound to other sites on the NA tetramer. The utility of bivalent or bifunctional scFvs with short linkers may therefore be restricted by the steric constraints imposed by binding multivalent antigens. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642070     DOI: 10.1006/jmbi.1998.1794

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

Review 1.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.

Authors:  Ian C Wilkinson; Catherine J Hall; Vaclav Veverka; Jiye Y Shi; Frederick W Muskett; Paul E Stephens; Richard J Taylor; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

3.  Determination of Rigidity of Protein Bound Au(144) Clusters by Electron Cryomicroscopy.

Authors:  Jonathan Z Sexton; Christopher J Ackerson
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2010-09-30       Impact factor: 4.126

4.  Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.

Authors:  Francisco Miguel Cardoso; Lorena Itatí Ibañez; Silvie Van den Hoecke; Sarah De Baets; Anouk Smet; Kenny Roose; Bert Schepens; Francis J Descamps; Walter Fiers; Serge Muyldermans; Ann Depicker; Xavier Saelens
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

Review 5.  Function and 3D structure of the N-glycans on glycoproteins.

Authors:  Masamichi Nagae; Yoshiki Yamaguchi
Journal:  Int J Mol Sci       Date:  2012-07-06       Impact factor: 6.208

6.  The 3D structure analysis of SARS-CoV S1 protein reveals a link to influenza virus neuraminidase and implications for drug and antibody discovery.

Authors:  Xue Wu Zhang; Yee Leng Yap
Journal:  Theochem       Date:  2004-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.